PHARMEXPERT 2026: The Pharmaceutical Market Under New Regulatory Framework
Ukraine’s pharmaceutical industry is rapidly evolving: new registration procedures, eCTD implementation, stricter requirements for evidence-based data, and changes in pricing and access to therapy. It is no longer enough for businesses to simply track these changes — they must understand their underlying logic and practical impact on commercial models.
On May 12 in Kyiv, a forum organized by Proxima Research International in partnership with the State Expert Centre of the Ministry of Health of Ukraine will bring together regulators and industry for an open dialogue on the most pressing regulatory changes.
Key topics:
Regulatory transformation of Ukraine’s pharmaceutical market
Medicinal product registration and bioequivalence studies
eCTD development and digitalization of regulatory procedures
Marketing practices and regulatory restrictions
New models of medicine access and regulatory policy
Who should attend: senior management of pharmaceutical companies, pharmacy chains and distributors, heads of regulatory and medical departments, representatives of consulting, analytics, and government bodies.
